This website was discontinued on 20/12/2022. Visit the new website at www.fct.pt.
The information may be unavailable due to the results not being approved or confirmed. In particular, when a call includes regions where projects are cofunded by EC funds and others where that is not the case, confirmation or approval may be not simultaneous.
Murderous Venom - Towards a Universal Antidote Against Snakebite. Pedro Manuel Azevedo Alexandrino Fernandes, REQUIMTE - Rede de Química e Tecnologia - Associação (REQUIMTE-P). €249,750.
Targeting human macrophage galactose C-type lectin towards the development of innovative and alternative cancer therapies. Filipa Marcelo, NOVA.ID.FCT - Associação para a Inovação e Desenvolvimento da FCT (NOVA.ID.FCT). €249,395.